| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Anderson GM 3d, Braun G, ... |
Absolute configuration and psychotomimetic activity |
NIDA Res Monogr |
1978 |
| Johnson MP, Hoffman AJ, N... |
Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... |
Eur J Pharmacol |
1986 |
| Nichols DE |
Differences between the mechanism of action of MDMA, MBDB, and the cla... |
J Psychoactive Drugs |
1986 |
| Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
| Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
| Battaglia G, De Souza EB |
Pharmacologic profile of amphetamine derivatives at various brain reco... |
NIDA Res Monogr |
1989 |
| Dimpfel W, Spuler M, Nich... |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... |
Psychopharmacology (... |
1989 |
| Johnson M, Hanson GR, Gib... |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... |
Eur J Pharmacol |
1989 |
| Lowy MT, Nash JF Jr, Melt... |
Selective reduction of striatal type II glucocorticoid receptors in ra... |
Eur J Pharmacol |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Azmitia EC, Murphy RB, Wh... |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... |
Brain Res |
1990 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
| Nash JF |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in th... |
Life Sci |
1990 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA and related compounds: a new ... |
Ann N Y Acad Sci |
1990 |
| Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
| Piercey MF, Lum JT, Palme... |
Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminer... |
Brain Res |
1990 |
| Yousif MY, Fitzgerald RL,... |
Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... |
Drug Alcohol Depend |
1990 |
| Ali SF, Chang LW, Slikker... |
Biogenic amines as biomarkers for neurotoxicity |
Biomed Environ Sci |
1991 |
| Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
| Glennon RA |
Phenylalkylamine stimulants, hallucinogens, and designer drugs |
NIDA Res Monogr |
1991 |
| Nash JF, Brodkin J |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dop... |
J Pharmacol Exp Ther |
1991 |
| Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
| Park WK, Azmitia EC |
5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat b... |
Ann N Y Acad Sci |
1991 |
| Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
| Rudnick G, Wall SC |
The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamin... |
Proc Natl Acad Sci |
1992 |
| Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
| Glennon RA, Higgs R |
Investigation of MDMA-related agents in rats trained to discriminate M... |
Pharmacol Biochem Be... |
1992 |
| Glennon RA, Higgs R, Youn... |
Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane... |
Pharmacol Biochem Be... |
1992 |
| Herndon JL, Pierson ME, G... |
Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... |
Pharmacol Biochem Be... |
1992 |
| Johnson M, Mitros K, Ston... |
Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... |
J Pharmacol Exp Ther |
1992 |
| Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
| Finnegan KT, Calder L, Cl... |
Effects of L-type calcium channel antagonists on the serotonin-depleti... |
Brain Res |
1993 |
| Gu XF, Azmitia EC |
Integrative transporter-mediated release from cytoplasmic and vesicula... |
Eur J Pharmacol |
1993 |
| Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
| Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
| Tirzite D, Tirzitis G, Vi... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| Bronson ME, Jiang W, Clar... |
Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken |
Brain Res Bull |
1994 |
| Colado MI, Green AR |
A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of ... |
Br J Pharmacol |
1994 |
| Kramer K, Azmitia EC, Whi... |
In vitro release of [3H]5-hydroxytryptamine from fetal and maternal br... |
Brain Res Dev Brain ... |
1994 |
| Campbell DB |
The use of toxicokinetics for the safety assessment of drugs acting in... |
Mol Neurobiol |
1995 |
| Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
| Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |
| Yamamoto BK, Nash JF, Gud... |
Modulation of methylenedioxymethamphetamine-induced striatal dopamine ... |
J Pharmacol Exp Ther |
1995 |
| Burns N, Olverman HJ, Kel... |
Effects of ecstasy on aldosterone secretion in the rat in vivo and in ... |
Endocr Res |
1996 |
| Milroy CM, Clark JC, Forr... |
Pathology of deaths associated with 'ecstasy' and 'eve' misuse |
J Clin Pathol |
1996 |
| Finnegan KT, Taraska T |
Effects of glutamate antagonists on methamphetamine and 3,4-methylened... |
J Neurochem |
1996 |
| Malberg JE, Sabol KE, Sei... |
Co-administration of MDMA with drugs that protect against MDMA neuroto... |
J Pharmacol Exp Ther |
1996 |
| Marona-Lewicka D, Rhee GS... |
Reinforcing effects of certain serotonin-releasing amphetamine derivat... |
Pharmacol Biochem Be... |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Sprague JE, Johnson MP, S... |
Studies on the mechanism of p-chloroamphetamine neurotoxicity |
Biochem Pharmacol |
1996 |
| Dulawa SC, Geyer MA |
Psychopharmacology of prepulse inhibition in mice |
Chin J Physiol |
1996 |
| Murray TK, Williams JL, M... |
The spin trap reagent PBN attenuates degeneration of 5-HT neurones in ... |
Neuropharmacology |
1996 |
| Seiden LS, Sabol KE |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... |
NIDA Res Monogr |
1996 |
| Curran HV, Travill RA |
Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MD... |
Addiction |
1997 |
| Nakahara Y, Kikura R |
Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethampheta... |
Biol Pharm Bull |
1997 |
| Crespi D, Mennini T, Gobb... |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... |
Br J Pharmacol |
1997 |
| Colado MI, O'Shea E, Gran... |
In vivo evidence for free radical involvement in the degeneration of r... |
Br J Pharmacol |
1997 |
| Colado MI, O'Shea E, Gran... |
A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones ... |
Br J Pharmacol |
1997 |
| Zheng Y, Russell B, Schmi... |
The effects of aminorex and related compounds on brain monoamines and ... |
J Pharm Pharmacol |
1997 |
| Taraska T, Finnegan KT |
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-met... |
J Pharmacol Exp Ther |
1997 |
| Martinez DL, Geyer MA |
Characterization of the disruptions of prepulse inhibition and habitua... |
Neuropsychopharmacol... |
1997 |
| Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
| Schechter MD |
Drug-drug discrimination: stimulus properties of drugs of abuse upon a... |
Pharmacol Biochem Be... |
1997 |
| Kikura R, Nakahara Y, Mie... |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxyme... |
Forensic Sci Int |
1997 |
| Huether G, Zhou D, Ruther... |
Causes and consequences of the loss of serotonergic presynapses elicit... |
J Neural Transm |
1997 |
| Malberg JE, Seiden LS |
Small changes in ambient temperature cause large changes in 3,4-methyl... |
J Neurosci |
1998 |
| Muck-Seler D, Takahashi S... |
The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... |
Brain Res |
1998 |
| Schechter MD |
'Candyflipping': synergistic discriminative effect of LSD and MDMA |
Eur J Pharmacol |
1998 |
| Lauerma H, Wuorela M, Hal... |
Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymeth... |
Biol Psychiatry |
1998 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Aguirre N, Barrionuevo M,... |
The role of dopaminergic systems in the perinatal sensitivity to 3, 4-... |
J Pharmacol Exp Ther |
1998 |
| Cadet JL, Brannock C |
Free radicals and the pathobiology of brain dopamine systems |
Neurochem Int |
1998 |
| O'Shea E, Granados R, Est... |
The relationship between the degree of neurodegeneration of rat brain ... |
Neuropharmacology |
1998 |
| Kramer HK, Poblete JC, Az... |
Characterization of the translocation of protein kinase C (PKC) by 3,4... |
Neuropsychopharmacol... |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Kankaanpaa A, Meririnne E... |
The acute effects of amphetamine derivatives on extracellular serotoni... |
Pharmacol Biochem Be... |
1998 |
| Dafters RI, Lynch E |
Persistent loss of thermoregulation in the rat induced by 3,4-methylen... |
Psychopharmacology (... |
1998 |
| Sabol KE, Seiden LS |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... |
Brain Res |
1998 |
| Metzger RR, Hanson GR, Gi... |
3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine tr... |
Eur J Pharmacol |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Nagilla R, Newland MC, Sn... |
Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine... |
Eur J Pharmacol |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Yeh SY, Dersch C, Rothman... |
Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induce... |
Synapse |
1999 |
| Shankaran M, Yamamoto BK,... |
Involvement of the serotonin transporter in the formation of hydroxyl ... |
Eur J Pharmacol |
1999 |
| Jones AL, Simpson KJ |
Review article: mechanisms and management of hepatotoxicity in ecstasy... |
Aliment Pharmacol Th... |
1999 |
| Walker TM, Davenport-Jone... |
The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its... |
Cell Biol Toxicol |
1999 |
| Stein DJ, Rink J |
Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors |
J Clin Psychiatry |
1999 |
| Shankaran M, Yamamoto BK,... |
Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced form... |
J Neurochem |
1999 |
| McCreary AC, Bankson MG, ... |
Pharmacological studies of the acute and chronic effects of (+)-3, 4-m... |
J Pharmacol Exp Ther |
1999 |
| Beitia G, Cobreros A, Sai... |
3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: ef... |
Liver |
1999 |
| Colado MI, O'Shea E, Este... |
In vivo evidence against clomethiazole being neuroprotective against M... |
Neuropharmacology |
1999 |
| Vollenweider FX, Gamma A,... |
Is a single dose of MDMA harmless? |
Neuropsychopharmacol... |
1999 |
| Malpass A, White JM, Irvi... |
Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-... |
Pharmacol Biochem Be... |
1999 |
| Vollenweider FX, Remensbe... |
Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensor... |
Psychopharmacology (... |
1999 |
| Scearce-Levie K, Viswanat... |
Locomotor response to MDMA is attenuated in knockout mice lacking the ... |
Psychopharmacology (... |
1999 |
